Determination of cut-off levels for on-clopidogrel platelet aggregation based on functional CYP2C19 gene variants in patients undergoing elective percutaneous coronary intervention-Reference-Cited by-同舟云学术

Determination of cut-off levels for on-clopidogrel platelet aggregation based on functional CYP2C19 gene variants in patients undergoing elective percutaneous coronary intervention

Published:2011-12 Issue:6 Volume:128 Page:e130-e136
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Ono Takamichi,Kaikita Koichi,Hokimoto Seiji,Iwashita Satomi,Yamamoto Koichiro,Miyazaki Yuji,Horio Eiji,Sato Koji,Tsujita Kenichi,Abe Tomohide,Deguchi Mariko,Tayama Shinji,Sumida Hitoshi,Sugiyama Seigo,Yamabe Hiroshige,Nakamura Sunao,Nakagawa Kazuko,Ogawa Hisao

Publisher

Elsevier BV

Subject

Hematology

Reference46 articles.

1. Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N Engl J Med,2001

2. Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study;Mehta;Lancet,2001

3. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial;Steinhubl;JAMA,2002

4. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial;Chen;Lancet,2005

5. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation;Sabatine;N Engl J Med,2005

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of stroke in CYP2C19 LoF polymorphism carrier coronary artery disease patients undergoing clopidogrel therapy: An ethnicity-based updated meta-analysis;European Journal of Internal Medicine;2021-08

2. Differential Impact of Clinical and Genetic Factors on High Platelet Reactivity in Patients with Coronary Artery Disease Treated with Clopidogrel and Prasugrel;Journal of Atherosclerosis and Thrombosis;2021

3. Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention;JAMA;2020-08-25

4. Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease;Thrombosis and Haemostasis;2019-07-22

5. Clopidogrel Pharmacogenetics;Circulation: Cardiovascular Interventions;2019-04